AlphaFold predicted structure
ARG1 · P05089

Mean pLDDT
97.0/ 100
Very high
322 residues
Confidence breakdown
- Very high(≥ 90)96%
- Confident(70–90)3%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
arginase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Childhood onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalHereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+5 more panels — install the extension to see the full list inline on any page.
Argininemia
arginase deficiency
type 2 diabetes mellitus
hereditary disease
obesity disorder
metabolic syndrome
Abnormality of the skeletal system
cervical carcinoma
diabetes mellitus
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Arginase-1
Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys
ARG1 · P05089

Mean pLDDT
97.0/ 100
Very high
322 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0